1. Home
  2. ATHM vs ZLAB Comparison

ATHM vs ZLAB Comparison

Compare ATHM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATHM

Autohome Inc.

HOLD

Current Price

$22.74

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$18.31

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATHM
ZLAB
Founded
2008
2013
Country
China
China
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
ATHM
ZLAB
Price
$22.74
$18.31
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$28.00
$49.60
AVG Volume (30 Days)
656.0K
714.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
9.83%
N/A
EPS Growth
N/A
38.46
EPS
N/A
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
N/A
$9.75
Revenue Next Year
$4.77
$26.03
P/E Ratio
$12.13
N/A
Revenue Growth
N/A
15.33
52 Week Low
$15.57
$15.96
52 Week High
$29.92
$39.64

Technical Indicators

Market Signals
Indicator
ATHM
ZLAB
Relative Strength Index (RSI) 70.23 39.86
Support Level $21.78 $16.84
Resistance Level $23.96 $19.55
Average True Range (ATR) 0.78 0.76
MACD 0.10 -0.25
Stochastic Oscillator 78.53 4.64

Price Performance

Historical Comparison
ATHM
ZLAB

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent, and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead-generation service provider in China's online auto platform media advertising market, in terms of media services and lead-generation revenue.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: